Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,382 INR | -0.40% | -2.32% | -5.77% |
Strengths
- According to sales estimates from analysts polled by Standard & Poor's, the company is among the best with regard to growth.
- The earnings growth currently anticipated by analysts for the coming years is particularly strong.
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- The group's activity appears highly profitable thanks to its outperforming net margins.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- The company appears highly valued given the size of its balance sheet.
- The company is not the most generous with respect to shareholders' compensation.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last few months, analysts have been revising downwards their earnings forecast.
Ratings chart - Surperformance
Sector: Software
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-5.77% | 444M | - | ||
+8.14% | 3,022B | C+ | ||
+4.28% | 81.91B | B | ||
+3.40% | 76.64B | B+ | ||
-16.54% | 52.31B | B+ | ||
+35.85% | 51.96B | D+ | ||
-22.85% | 47.77B | B- | ||
+23.11% | 43.3B | D+ | ||
+64.59% | 38.29B | D+ | ||
-14.17% | 25.1B | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- NUCLEUS Stock
- Ratings Nucleus Software Exports Limited